Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a Phase II study of toripalimab combined with surufatinib for locally advanced thyroid cancer, with details on study participation, treatment arms, outcomes, and contacts, replacing a 403 error page.
    Difference
    54%
    Check dated 2026-11-08T13:38:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T14:45:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH announcement banner appears, explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T15:41:21.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer updates its revision identifier from v3.7.1 to v3.7.2. The study record continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T20:48:13.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:49:15.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page content and the accompanying navigation elements from the page. This change eliminates the error-page messaging and results in a standard page layout for the study details.
    Difference
    0.5%
    Check dated 2026-09-27T20:31:52.000Z thumbnail image

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.